Sepsis of newborn due to other and unspecified staphylococci
ICD-10 P36.3 is a billable code used to indicate a diagnosis of sepsis of newborn due to other and unspecified staphylococci.
Sepsis in newborns is a critical condition characterized by a systemic inflammatory response to infection, which can lead to multi-organ dysfunction. In the case of P36.3, the sepsis is specifically attributed to other and unspecified staphylococci, which may include strains not typically identified in standard testing. Staphylococcal infections can arise from various sources, including maternal colonization during labor, skin flora, or environmental exposure. Newborns, particularly preterm infants or those with low birth weight, are at heightened risk due to their immature immune systems. Symptoms may include lethargy, poor feeding, temperature instability, and respiratory distress. Early recognition and prompt treatment with appropriate antibiotics are crucial to improve outcomes. The management of sepsis in neonates often requires a multidisciplinary approach, including neonatologists, nursing staff, and infection control specialists, to ensure comprehensive care and monitoring.
Detailed clinical notes on the infant's condition, including vital signs, laboratory results, and treatment plans.
Infants presenting with lethargy and temperature instability in the NICU, requiring sepsis workup.
Accurate documentation of maternal health history and potential risk factors for infection.
Comprehensive history and physical examination notes, including any follow-up care for the infant.
Pediatric follow-up visits for infants discharged after treatment for sepsis.
Consideration of long-term effects of sepsis on growth and development.
Used when a newborn with sepsis requires intensive monitoring and management in the NICU.
Detailed notes on the infant's condition, interventions, and response to treatment.
Neonatologists should ensure that all critical care services are documented to support billing.
Common signs include lethargy, poor feeding, temperature instability, irritability, and respiratory distress. Early identification is crucial for effective management.
Diagnosis typically involves clinical evaluation, blood cultures, and laboratory tests to assess inflammatory markers and organ function.
Treatment usually involves intravenous antibiotics, supportive care, and monitoring in a NICU setting, with adjustments based on culture results.
